The binding of lncRNA GAS5 with Nrf2 transcription factor helped better understand the prevention mechanism of AML and provided potential biomarker for the study on AML to reduce the recurrence of AML and prolong patient survival. This evidence concerns the gene GAS5 and acute myeloid leukemia.